Knee Kinesiography for Anterior Knee Pain
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if the Emovi 3D Knee Assessment Device (also known as the Knee Kinesiography System) can enhance treatment for anterior knee pain through physical therapy. Participants will either receive standard care or have their therapy guided by this device, which recommends exercises based on a detailed knee assessment. The trial seeks active-duty service members at Fort Liberty and Schofield Barracks who have knee pain without other lower limb injuries or a history of knee surgery. As an unphased trial, participants can contribute to innovative research that may improve knee pain treatment options.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the Emovi 3D Knee Assessment Device is safe for use in physical therapy?
Research has shown that the Emovi 3D Knee Assessment Device is easy to use and well accepted by patients. This device guides physical therapy for knee pain by providing detailed information about knee movement. It tracks knee movement in real time, allowing therapists to customize treatments to fit individual needs.
Regarding safety, no problems have been reported with using this device. As a diagnostic tool rather than a medication or surgery, it carries very low risks. The main goal is to improve therapy results by providing therapists with better information. Overall, evidence suggests it is a safe choice for managing knee pain.12345Why are researchers excited about this trial?
Researchers are excited about the Knee Kinesiography (KneeKG) assessment device because it offers a personalized approach to treating anterior knee pain. Unlike standard physical therapy, which follows general guidelines, the KneeKG provides detailed insights into an individual's knee biomechanics. This allows therapists to tailor exercises specifically to the patient's unique impairments, potentially leading to more effective and faster relief. By targeting the precise biomechanical issues, the KneeKG could revolutionize how we approach knee pain management, making treatments more efficient and personalized.
What evidence suggests that the Emovi 3D Knee Assessment Device is effective for anterior knee pain?
Research shows that the Emovi 3D Knee Assessment Device helps identify specific knee movement problems by providing a detailed view of knee motion and highlighting any issues. In this trial, participants in the intervention arm will receive physical therapy guided by impairments identified with the KneeKG. Studies have found that this information enables therapists to create exercises tailored to each patient's needs, focusing on the exact problems causing knee pain. Early results suggest that this method leads to better outcomes than standard physical therapy alone, potentially reducing pain and improving knee function when therapy is guided by Knee Kinesiography results.12567
Who Is on the Research Team?
Don L Goss, DPT, PhD
Principal Investigator
Womack Army Medical Center
Are You a Good Fit for This Trial?
This trial is for active duty service members aged 18-50 stationed at Fort Liberty and Schofield Barracks, diagnosed with patellofemoral pain. It's not open to those with a history of traumatic knee injury, rheumatoid or neurological diseases, previous knee surgery, other lower limb injuries, individuals moving from the station within three months, or pregnant women.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline measures and receive a Knee Kinesiography exam
Treatment
Participants receive either KneeKG informed care or usual care for 4 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Emovi 3D Knee Assessment Device
Emovi 3D Knee Assessment Device is already approved in United States, Canada, European Union for the following indications:
- Assessment of knee motion for patients with impaired movement functions of an orthopedic cause
- Assessment of knee motion for patients with impaired movement functions of an orthopedic cause
- Assessment of knee motion for patients with impaired movement functions of an orthopedic cause
Find a Clinic Near You
Who Is Running the Clinical Trial?
Womack Army Medical Center
Lead Sponsor
Medical Technology Enterprise Consortium
Collaborator
The Geneva Foundation
Collaborator